Axon Ligands (TM) - List of New Ligands 2012

	Chemistry Service Platform - CRO in Medicinal Chemistry × close
Axon Ligands (TM) - alphabetic: [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z]

Axon Ligands^TM for Drug Discovery

Prime Source

High Value

High Quality

We make as Drug Standards

Serving diversified application fields

With expertise like CNS reagents

Brand-new like kinase inhibitors...

[e-catalogue available in pdf]

Products - Axon Ligands^TM - List of New Ligands (by date added) 2011 2010 2009 2008

New Ligands Released: A 784168 \| TRPV1 antagonist IMS 2186 \| Apoptosis inducer MS 275 \| HDAC inhibitor NVP-BHG712 \| EphB4 inhibitor AP 24534 \| BCR-ABL inhibitor VU 0364770 \| mGuR4 PAM VU 0361737 \| mGuR4 PAM Erastin \| VDAC2 inhibitor BH3I-1 \| Bcl-xL antagonist PF 04691052 \| PI3K/mTOR inh. ARQ 197 \| MET inhibitor A 66 \| PI3K p110α inhibitor Rolofylline M1-trans \| A1 antag. Rolofylline M1-cis \| A1 antag. PCI 34051 \| HDAC8 inhibitor Torin 1 \| mTOR inhibitor Torin 2 \| mTOR inhibitor DBeQ \| p97 inhibitor MK 0822 \| Cathepsin K inhibitor CK 1827452 \| Myosin activator Sulfonamide 13 \| JAK2 inhibitor Eeyarestatin 1 \| ERAD inhibitor CCT 137690 \| Aurora inhibitor UNC 0224 \| HMTase inhibitor GW 788388 \| TGF-βR1 inhibitor C646 \| p300 HAT inhibitor Wiskostatin \| N-WASP inhibitor N6022 \| GSNOR inhibitor XL PI3K/mTOR inh. \| Axon 1706 PKI 587 \| PI3K/mTOR inhibitor 2012 APR BIX 02189 \| MEK5/ERK5 inhibitor Cabozantinib \| MET/VEGFR2 inh. GS 39783 \| GABAB PAM Pyroxamide \| HDAC inhibitor CCT007093 \| PPM1D inhibitor NQDI-1 \| ASK1 inhibitor S 18986 \| AMPA PAM PF 4800567 \| CK 1e inhibitor VU 0360223 \| mGluR5 antagonist NVP-BGJ398 \| FGFR inhibitor MC 1568 \| IIa HDAC inhibitor VX 745 \| p38α MAPK inhibitor BAN ORL 24 \| NOP antagonist JTC 801 \| NOP antagonist Bortezomib \| Proteasome inhibitor LB 42708 \| FTase inhibitor PDE5 inhibitor \| Axon 1709	2012 MAR (S)-3,5-DHPG \| mGluR1 agonist (RS)-3,5-DHPG \| mGluR1 agonist CXCR3 antagonist \| Axon 1800 SCH 727965 \| CDK inhibitor Nav1.7 blocker \| Axon 1780 Nav1.7 blocker \| Axon 1791 VU 0255035 \| M1 antagonist GSK 2126458 \| PI3K/mTOR inh. BKM 120 \| PI3K inhibitor SC 66 \| AKT inhibitor CaSR antagonist \| Axon 1732 FXR 450 \| FXR inhibitor Kv1.3 blocker \| Axon 1735 AMG 900 \| Aurora inhibitor WP 1130 \| DUB inhibitor SB 939 \| HDAC inhibitor AMG 706 \| VEGFR inhibitor 2012 FEB GDC 0980 \| PI3K/mTOR inhibitor VU 0238429 \| M5 PAM MG 149 \| Tip60 HAT inhibitor AZ 960 \| JAK2 inhibitor SA 4503 \| Sigma-1 agonist TG 003 \| Clk inhibitor D-Atazanivir \| Protease inhibitor SCH 530348 \| PAR1 antagonist HMR 1098 \| KATP chan. blocker 2012 JAN Iobenguane \| MIBG standard PNU 100480 \| Anti-TB agent BVT 2733 \| 11β-HSD1 inhibitor Doxercalciferol \| VDR agonist CoPo-22 \| CFTR CoPo T 1776Na \| PAI-1 inhibitor GSK 1120212 \| MEK inhibitor CDDO-Me \| Apoptosis inducer ICG 001 \| Wnt/CREB inhibitor D-106669 \| PI3K inhibitor Bazedoxifene \| SERM 2011 DEC (-)-Bay-K8644 \| Ca chan. activator (+)-Bay-K8644 \| Ca chan. modulator (S)-WAY100135 \| 5-HT1A antag. (R)-WAY100135 \| 5-HT1A antag. NXY 059 \| radical scavenger A 770041 \| Lck inhibitor EGFR inhibitor [879127-07-8] Apixaban \| Factor Xa inhibitor dl-hCPT \| Topo-1 inhibitor ADL 5859 \| δ opioid agonist AZ 12216052 \| mGluR8 PAM PF 3845 \| FAAH inhibitor VU 0357017 \| M1 PAM MK 0354 \| Naicin partial agonist SEW 2871 \| S1P1 agonist	BMS 345541 \| IKK inhibitor WAY 208466 \| 5-HT6 agonist SB 242084 \| 5-HT2C antagonist 2011 NOV PPP \| CYP2B6 inhibitor Brimonidine \| α2 agonist PAC-1 \| Procaspase activator AMD 3100 \| CXCR4 antagonist Kifunensine \| Mannosidase inh. Palomid 529 \| Akt/mTOR inhibitor Venlafaxine \| SNRI Bexarotene \| RXR agonist A 83-01 \| ALK5 inhibitor BI 6727 \| PLK1 inhibitor Tivozanib \| VEGFR inhibitor GB 83 \| PAR2 antagonist 2011 OCT GSK 690693 \| AKT inhibitor AC 220 \| FLT3 inhibitor SLV 319 \| CB1 antagonist BXL 628 \| VDR agonist Temsirolimus \| mTOR inhibitor Bay K8644 \| Ca chan. activator REP 3123 \| MetRS inhibitor REP 8839 \| MetRS inhibitor Orvepitant \| NK1 antagonist FR 180204 \| ERK inhibitor BIO \| GSK3 inhibitor 2011 SEP OSI 906 \| IGF-1R/IR inhibitor Shz-1 \| Differentiating agent SU 5402 \| FGFR inhibitor BIX 01294 \| HMTase inhibitor RG 108 \| DNA methylation inh. YS 49 \| antithrombotic MDL 201012 \| M3 antagonist STF 083010 \| IRE1 inhibitor PF 02341066 \| c-Met/ALK inh. 2011 AUG KU 55933 \| ATM inhibitor LY 317615 \| PKCβ inhibitor GSK 461364 \| PLK1 inhibitor CYT 387 \| JAK1/2 inhibitor Asoprisnil \| PR modulator RU 58841 \| Antiandrogen AEE 788 \| EGFR/VEGFR inhibitor MK 2206 \| AKT inhibitor Y-27632 \| ROCK inhibitor 2011 JULY R 406 \| Syk inhibitor BAY 73-4506 \| RTK inhibitor BINA \| mGluR2 PAM Danoprevir \| HCV protease inh. PD 173074 \| FGFR inhibitor TWS 119 \| GSK-3β inhibitor SCIO 469 \| p38 MAPK inhibitor See more ligands in 2011

2012: NEW MAR FEB JAN; 2011: DEC NOV OCT SEP AUG JULY JUN MAY APR MAR FEB JAN; 2010 2009 2008